# Creatine Supplementation During GLP-1a Therapy

> **NCT07625202** · NA · RECRUITING · sponsor: **University of Saskatchewan** · enrollment: 40 (estimated)

## Conditions studied

- Sarcopenia

## Interventions

- **DIETARY_SUPPLEMENT:** Dietary supplementation during a 12 week resistance-training program (creatine)
- **DIETARY_SUPPLEMENT:** Dietary supplementation during a 12 week resistance-training program (placebo)

## Key facts

- **NCT ID:** NCT07625202
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-25
- **Primary completion:** 2027-05-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07625202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07625202, "Creatine Supplementation During GLP-1a Therapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07625202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*